The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Atherosclerosis

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2010.02.018PMID 20223458PMCID PMC2897919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Divergent Effects of α-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype

  2010cited by this paper
• Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.

  2010cited by this paper
• Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

  2008influential reference
• Haptoglobin Genotype

  2008cited by this paper
• Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

  2008cited by this paper
• A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.

  2008cited by this paper
• The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

  2007cited by this paper
• Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial

  2007cited by this paper
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Vitamin E and cardiovascular health: does sex matter?

  2005cited by this paper
• Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women ’ s Health Study : A Randomized Controlled Trial

  2005influential reference
• Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

  2005cited by this paper
• The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients.

  2005cited by this paper
• Vitamin E and Cardiovascular Health

  2005cited by this paper
• Is there any hope for vitamin E?

  2005cited by this paper
• The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.

  2004cited by this paper
• Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials

  2004cited by this paper
• Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

  2003cited by this paper
• Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

  2003cited by this paper
• Haptoglobin phenotype and coronary artery collaterals in diabetic patients.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

  2002cited by this paper
• Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis?

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

  2001cited by this paper
• Primäre Prävention kardiovaskulärer Ereignisse durch ASS und Vitamin E PPP das “Primary Prevention Project”

  2001cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Baseline Characteristics of Participants in the Women's Health Study

  2000cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

  1996cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper

• Addressing Micronutrient Requirements in Type 2 Diabetes: An International Consensus Report.

  2026cites this paper
• Effect of Vitamin E (Alpha Tocopherol) Supplementation on Sports Performance of Male Weightlifters in Pakistan

  2025cites this paper
• Scrutinizing the antidiabetic, antidiarrheal, and anti-inflammatory activities of methanolic extract of pomegranate peel via different approaches

  2024cites this paper
• Unlocking the link between haptoglobin polymorphism and noninfectious human diseases: insights and implications

  2023cites this paper
• 100 Jahre Vitamin-E-Forschung: Status, Ausblick und zukünftige Entwicklungen

  2022cites this paper
• Interventional study with vitamin E in cardiovascular disease and meta-analysis.

  2021cites this paper
• Efficacy of Antioxidant Suplementation to Prevent Preeclampsia

  2021cites this paper
• The Peripheral Blood Expression of Lipoic Acid Synthetase Gene as an Early Marker for Diabetic Nephropathy

  2020cites this paper
• Effect of Proton Pump Inhibitors, Vitamin E and their co- administration on heart function and Oxidative Changes in Isoprenaline Induced Myocardial Infarction in Adult Male Albino Rats

  2020cites this paper
• Vitamin E Intake Is Associated with Lower Brain Volume in Haptoglobin 1-1 Elderly with Type 2 Diabetes

  2020cites this paper
• Effect of Vitamins and Dietary Supplements on Cardiovascular Health

  2020cites this paper
• Implications of Haptoglobin Genotype and Cardiovascular Risk in Patients with Diabetes

  2020cites this paper
• The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes

  2020cites this paper
• Vitamin E, high-density lipoproteins, and vascular protection in diabetes

  2020cites this paper
• Clinical Cardiovascular Disease Trials: The Vitamin E Case

  2019cites this paper
• Introduction: Why (Another) Book on Vitamin E?

  2019cites this paper
• Haptoglobin Genotype and a Promising Pharmacogenomic Approach to Prevent Diabetic Atherothrombosis with Vitamin E Supplementation

  2019cites this paper
• Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients

  2019cites this paper
• Synthesis of vitamin E succinate catalyzed by nano-SiO2 immobilized DMAP derivative in mixed solvent system

  2019cites this paper
• Haptoglobin Phenotype Among Arab Patients With Mental Disorders

  2018cites this paper
• Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation

  2018cites this paper
• Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design

  2018cites this paper
• The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus

  2018cites this paper
• Cardiovascular complications of type 1 diabetes: update on the renal link

  2017cites this paper
• Non-alcoholic fatty liver disease: bases for therapeutic roles of vitamin e and n-3 PUFA

  2017cites this paper
• Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes

  2017cites this paper
• Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.

  2017cites this paper
• Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments

  2017cites this paper
• The Epidemiology of Cardiovascular Disease in Adults with Type 1 Diabetes.

  2017cites this paper
• The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications

  2016cites this paper
• Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial

  2016cites this paper
• The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.

  2016cites this paper
• Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy

  2016cites this paper
• Glycaemic control modifies the haptoglobin 2 allele‐conferred susceptibility to coronary artery disease in Type 1 diabetes

  2016cites this paper
• α-Tocopherol Stereoisomers in Human Plasma Are Affected by the Level and Form of the Vitamin E Supplement Used.

  2015cites this paper
• Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women.

  2015cites this paper
• Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications.

  2015cites this paper
• Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.

  2015cites this paper
• Preeclampsia and Diabetes

  2015cites this paper
• Haptoglobin Phenotype , Preeclampsia and Response to Supplementation with Vitamins C and E in Pregnant Women with Type 1 Diabetes

  2015cites this paper
• Vascular oxidative stress, nitric oxide and atherosclerosis.

  2014cites this paper
• Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

  2014cites this paper
• Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.

  2014cites this paper
• Antioxidant Use in Humans - Successes and Failures 175

  2014cites this paper
• Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

  2014cites this paper
• Genotipo de la haptoglobina y riesgo de nefropatía diabética en pacientes con diabetes mellitus tipo 1: estudio en población española

  2014cites this paper
• Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the

  2014cites this paper
• Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes

  2014cites this paper
• Vitamin E and diabetic nephropathy in mice model and humans.

  2013cites this paper
• Haptoglobin Phenotype, Preeclampsia Risk and the Efficacy of Vitamin C and E Supplementation to Prevent Preeclampsia in a Racially Diverse Population

  2013cites this paper
• Patient selection and vitamin E treatment in diabetes mellitus

  2013cites this paper
• Haptoglobin 1-1 Genotype Is Associated With Poorer Cognitive Functioning in the Elderly With Type 2 Diabetes

  2013cites this paper
• Haptoglobin phenotype, pre‐eclampsia, and response to supplementation with vitamins C and E in pregnant women with type‐1 diabetes

  2013cites this paper
• Haptoglobin 1-1 Genotype Is AssociatedWith Poorer Cognitive Functioning in Type 2 Diabetic Elderly

  2013cites this paper
• Stress and Response in Relation to Coronary Artery Disease in Type 1 Diabetes

  2013cites this paper
• Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection

  2013cites this paper
• Oxidative Stress and Response in Relation to Coronary Artery Disease in Type 1 Diabetes

  2013cites this paper
• Preventive Effect of Antioxidant Vitamins on Cardiovascular Diseases

  2013cites this paper
• ビタミンEとハプトグロビンの遺伝子多型( 「ビタミンと遺伝子多型」-ビタミンE-)

  2013cites this paper
• Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?

  2013cites this paper
• Diabetic Cardiomyopathy: Cardiac Changes, Pathophysiological Mechanisms, Biologic Markers, and the Available Therapeutic Armamentarium

  2012cites this paper
• Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.

  2012cites this paper
• Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options

  2012cites this paper
• Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?

  2012cites this paper
• Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.

  2012cites this paper
• Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease

  2012cites this paper
• Macrophage Infiltration and Smooth Muscle Cells Content Associated With Haptoglobin Genotype in Human Atherosclerotic Carotid Plaques

  2012cites this paper
• The association of diabetes and dementia and possible implications for nondiabetic populations

  2011cites this paper
• Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.

  2011cites this paper
• Vitamins C and E: beneficial effects from a mechanistic perspective.

  2011cites this paper
• Changing the Face of Diabetic Care with Haptoglobin Genotype Selection and Vitamin E

  2011cites this paper
• Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.

  2011cites this paper
• Quality Control of HDL: Nutrition and Not Numbers May Determine HDL Functionality

  2011cites this paper
• Current conceptions of the etiology and risk factors for Alzheimer's disease and their possible implications on the design of dementia clinical trials

  2011cites this paper
• Antioxidant Vitamins and Their Use in Preventing Cardiovascular Disease

  2010cites this paper
• Haptoglobin: Basic and Clinical Aspects

  2010cites this paper
• Divergent Effects of α-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype

  2010cites this paper
• Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.

  2010cites this paper
• When Are Type 1 Diabetic Patients at Risk for Cardiovascular Disease?

  2010cites this paper
• Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: Results of the ATBC Study

  2010cites this paper
• High-density lipoprotein therapeutics and cardiovascular prevention.

  2010cites this paper
• 12 Antioxidant and B-vitamins and Atherosclerosis

  2010cites this paper
• Antioxidant and B-vitamins and Atherosclerosis

  2010cites this paper
• Reply to MG Traber and B Frei

  2010cites this paper
• Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.

  2010cites this paper
• Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.

  2009cites this paper
• Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly.

  2009cites this paper
• Haptoglobin genotype and renal function decline in t ype 1 diabetes Running title: Haptoglobin genotype and renal functi on in T1D

  2009cites this paper
• Pharmacogenomics and the prevention of vascular complications in diabetes mellitus

  2009cites this paper
• Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.

  2009cites this paper
• Modification of HDL structure and function in individuals with diabetes and the haptoglobin 2-2 genotype

  2009cites this paper
• Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction

  2009cites this paper
• Haptoglobin Genotype and Renal Function Decline in Type 1 Diabetes

  2009cites this paper
• Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants

  2008cites this paper
• Haptoglobin Genotype

  2008cites this paper
• Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.

  2008cites this paper
• Genetic polymorphisms as determinants for disease-preventive effects of vitamin E.

  2008cites this paper
• Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

  2008cites this paper
• Oxidative Stress in Type 2 Diabetes Mellitus

  2008cites this paper
• Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial

  2007cites this paper